3 nominees · 4 ballot items.
Four proposals: (1) Elect three Class III directors (James Celli, Davis Pilot III, Donald J. Trump, Jr.); (2) Ratify UHY LLP as independent auditors for 2026; (3) Approve an amendment to effect a reverse stock split of Class A common stock at a ratio between 1-for-5 and 1-for-15, subject to Board determination; (4) Approve the Amended and Restated 2023 Stock Incentive Plan (increase shares, add performance-based awards).
Elect three Class III directors nominated by the Board (James Celli, Davis Pilot III, Donald J. Trump, Jr.) to serve until the 2029 annual meeting.
Ratify the appointment of UHY LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
Approve an amendment to the restated certificate of incorporation to permit a reverse stock split of outstanding Class A common stock at a ratio of any whole number between 1-for-5 and 1-for-15, subject to determination by the Board.
This management proposal requests shareholder approval to amend the Company’s certificate of incorporation to authorize a reverse stock split of Class A common stock at a ratio the Board may select within the 1-for-5 to 1-for-15 range. The Board’s explicit objective is to raise the per-share price to meet NYSE listing standards (a minimum closing price and 30‑trading‑day average of $1.00) after receiving a notice of noncompliance; if not approved, the Company risks delisting. If approved by shareholders, the Board retains discretion whether and when to file the amendment and to select the precise ratio (and may abandon the plan if conditions change), and the split would take effect only upon filing with the Delaware Secretary of State. The proposal contemplates cash payments in lieu of fractional shares and proportional adjustments to outstanding equity awards and the share reserve under equity plans. The Board notes risks and disadvantages — possible negative investor perception of reverse splits, potential post‑split share price declines, reduced liquidity and increased odd‑lot holdings, and an effective increase in available authorized shares for future issuances — and reserves the right to weigh market and NYSE conditions before implementing the split. Management frames the split as a targeted remedy to regain compliance and improve marketability to institutional investors, but it acknowledges there is no assurance the split will achieve sustained compliance or attract new investors. The Board also emphasizes that the reverse split is not intended as an anti‑takeover device and that it will continue to evaluate listing criteria and market conditions prior to any implementation. From a governance perspective, shareholder approval grants the Board flexibility while preserving its responsibility to act in stockholders’ best interests when and if the split is implemented.
Approve the Amended and Restated 2023 Stock Incentive Plan which increases the share reserve (adds 1,000,000 shares), adds performance-based awards provisions, and makes clarifying updates to the 2023 Incentive Plan.
This management proposal seeks shareholder approval of an amended and restated equity incentive plan that (i) increases the share reserve by adding 1,000,000 additional shares (and establishes an overarching share pool described in the proxy), (ii) explicitly authorizes performance‑based awards, and (iii) makes clarifying and administrative updates. Management frames the change as necessary to preserve the Company’s ability to attract, retain and motivate key employees, directors and consultants through long‑term equity incentives and to align their interests with stockholders. The Amended Plan contains standard features — grants of incentive and nonstatutory options, SARs, restricted stock and RSUs, limits on repricing without shareholder approval, transferability restrictions, and tax and withholding provisions — while adding guardrails such as limits on annual compensation value to non‑employee directors and an Earnout Pool tied to merger‑related metrics. The Board also describes anti‑abuse and Section 409A compliance provisions and permits the committee to substitute awards in transactions and to adjust awards in corporate events. Approval would enlarge the available share pool under the Plan and permit future grants (including performance‑based awards) that management believes are important for retention and recruiting, while retaining shareholder protections against repricing and requiring shareholder approval where exchange rules dictate. The Company notes that, if not approved, the existing plan will remain in effect but without the additional shares and features proposed, potentially constraining future equity grant capacity and the flexibility of compensation programs. The Board recommends FOR, asserting that the benefits of maintaining a competitive equity program outweigh the dilution and other costs associated with an increased share reserve.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Alyeska Investment Group, L.P. | 3.1% | 1,526,649 | $809K |
| 2 | Sepio Capital, LP | 2.5% | 1,203,704 | $638K |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4% | 1,146,397 | $608K |
| 4 | Harvest Investment Services, LLC | 1.4% | 660,746 | $350K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 423,859 | $225K |
| 6 | Corient Private Wealth LLC | 0.6% | 274,776 | $146K |
| 7 | BlackRock, Inc. | 0.5% | 251,645 | $133K |
| 8 | UBS Group AG | 0.4% | 205,535 | $109K |
| 9 | VANGUARD FIDUCIARY TRUST CO | 0.4% | 180,134 | $95K |
| 10 | CIBC Bancorp USA Inc. | 0.4% | 178,241 | $94K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.